WeCareToFeedDysphagia Tool for Caregiver Burden in Dementia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new website tool called WeCareToFeedDysphagia to determine if it can reduce stress for caregivers of dementia patients with swallowing difficulties. Researchers aim to assess whether the tool improves caregivers' well-being and benefits the patients' health. The trial compares caregivers using the tool with those who do not, though both groups can consult a swallowing expert if needed. It seeks caregivers who assist patients with swallowing issues at home and have access to a smartphone or computer. As an unphased trial, this study provides caregivers an opportunity to explore innovative support tools that could enhance their caregiving experience.
What prior data suggests that the WeCareToFeedDysphagia tool is safe for use in reducing caregiver burden?
Research has shown that the WeCareToFeedDysphagia tool is designed to reduce stress for caregivers of people with Alzheimer’s disease who have difficulty swallowing. Specific safety data on this tool is unavailable because it is a website, not a medication or physical treatment. Generally, using a website tool is considered safe since it doesn't involve taking drugs or undergoing procedures.
The trial aims to determine if the tool can ease caregiving by providing support and information. As an online resource, there are no reports of negative effects or side effects. Participants in the study will receive reminders to use the tool, encouraging its use without physical risk.12345Why are researchers excited about this trial?
Researchers are excited about the WeCareToFeedDysphagia tool because it offers a new way to support caregivers of individuals with dementia who struggle with dysphagia, which is difficulty in swallowing. Unlike traditional treatments that focus solely on direct medical interventions, this tool provides a digital platform to assist caregivers with practical strategies and reminders, potentially reducing their burden. By integrating technology with caregiver support, it aims to enhance the quality of care and improve outcomes for both caregivers and patients.
What evidence suggests that the WeCareToFeedDysphagia tool is effective for reducing caregiver burden in dementia?
Research has shown that the WeCareToFeedDysphagia tool is designed to reduce the burden and stress for caregivers of people with Alzheimer's disease and related dementias who have trouble swallowing. In this trial, some participants will access the WeCareToFeedDysphagia tool alongside enhanced control measures. Although specific data on this tool's effectiveness is limited, similar tools have shown promise in reducing caregiver stress and boosting confidence in managing daily tasks. Early studies suggest that such tools can significantly improve caregivers' lives by helping them handle everyday challenges more effectively. The researchers aim for WeCareToFeedDysphagia to provide similar benefits by offering practical support and resources.12346
Who Is on the Research Team?
Liron Sinvani, MD
Principal Investigator
Northwell Health
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the intervention group receive access to the WeCareToFeedDysphagia web tool and receive 3 text message reminders over 3 weeks to use the tool.
Survey Follow-up
Participants complete a remote, web-based survey three times: when enrolled in the study, at 1 month following patient leaving the hospital, and at 3 months following patient leaving the hospital.
Follow-up
Participants are monitored for outcomes such as care partner burden and quality of life at 1 and 3 months post hospital discharge.
What Are the Treatments Tested in This Trial?
Interventions
- WeCareToFeedDysphagia
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants receive usual care from their medical team and receive contact information for speech-language pathology follow-up care. Participants will also receive access to the WeCareToFeedDysphagia web tool and receive text message reminders to use the tool.
Participants receive usual care from their medical team and receive contact information for speech-language pathology follow-up care.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwell Health
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
National Institutes of Health (NIH)
Collaborator
Citations
WeCareToFeedDysphagia to Reduce Care-partner Burden ...
The goal of this clinical trial is to learn if a newly-created website tool, called WeCareToFeedDysphagia, helps to reduce feelings of burden in care ...
2.
ctv.veeva.com
ctv.veeva.com/study/wecaretofeeddysphagia-to-reduce-care-partner-burden-full-scale-rctWeCareToFeedDysphagia to Reduce Care-partner Burden ...
The goal of this clinical trial is to learn if a newly-created website tool, called WeCareToFeedDysphagia, helps to reduce feelings of ...
Web Tool for Caregiver Burden in Alzheimer's Disease
This trial tests a new website tool called WeCareToFeedDysphagia. The researchers aim to determine if this tool can reduce stress for caregivers of loved ...
Project Details
The R33 phase will determine the efficacy of WeCareToFeedDysphagia to reduce care-partner burden by: conducting a 24-month, full-scale RCT (N=406) at 11 ...
Website Tool for Reducing Burden in Dementia Care ...
This clinical trial is exploring whether a new website tool, called WeCareToFeedDysphagia, can help reduce the feelings of stress and burden experienced by ...
Reducing Burden in Care Partners of Community-Dwelling ...
The goal of this clinical trial is to learn if a newly-created website tool, called WeCareToFeedDysphagia, helps to reduce feelings of burden in care ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.